01 3Adenoscan/Lexiscan
02 2Lexiscan
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 769
2020 Revenue in Millions : 542
Growth (%) : 100
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 719
2021 Revenue in Millions : 768
Growth (%) : -6
Main Therapeutic Indication : Diagnostic
Currency : USD
2018 Revenue in Millions : 681
2017 Revenue in Millions : 628
Growth (%) : 9%
Main Therapeutic Indication : Diagnostic
Currency : USD
2016 Revenue in Millions : 629
2015 Revenue in Millions : 682
Growth (%) : -8
Main Therapeutic Indication : Diagnostic
Currency : USD
2017 Revenue in Millions : 670
2016 Revenue in Millions : 671
Growth (%) : -0.2
